The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty
This morning the 62nd session World Health Assembly agreed to a resolution on public health, innovation and intellectual property that, among other things, settled outstanding issues regarding the “stakeholders” for various parts of the Global Strategy and Plan of Action. (GS/PoA). With regard to the issue of a possible medical R&D treaty, the outcome of the negotiation was something of a split decision. On the one hand, the WHA agreed that the WHO would not be a stakeholder, in terms of the specific element of the WHO Global Strategy document. Continue Reading